comparemela.com
  1. Home
  2. Live Updates
  3. Stephenson Cancer Center - Breaking News

Latest Breaking News On - Stephenson cancer center - Page 7 : comparemela.com

Dr Richardson on the UPLIFT Trial of Upifitamab Rilsodotin in Ovarian Cancer

Debra L. Richardson, MD, FACS, FACOG, discusses outcomes seen with upifitamab rilsodotin in the phase 1/2 UPLIFT trial for patients with ovarian cancer.

United statesUniversity of oklahomaDebral richardsonPhasei programUniversity of oklahoma ou college medicineStephenson cancer centerOu healthGynecologic oncology

Journey Ends for Upifitamab Rilsodotin in NaPi2b+ Platinum-Resistant Ovarian Cancer

Debra L. Richardson, MD, FACS, FACOG, expands on results with upifitamab rilsodotin in platinum-resistant high-grade serous ovarian cancer.

University of oklahomaUnited statesOklahoma cityDebral richardsonPhasei programOu healthStephenson cancer centerUniversity of oklahoma ou college medicineGynecologic oncologyUpifitamab rilsodotinPlatinum resistant high grade serous ovarian cancerThe university of oklahoma college medicine

Annual Outpace Cancer Race Raises Money To Help Oklahomans Fight Cancer

Annual Outpace Cancer Race Raises Money To Help Oklahomans Fight Cancer
news9.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news9.com Daily Mail and Mail on Sunday newspapers.

United statesHeather wallerCancerheather wallerOu health stephenson cancer centerOu health sciences center onStephenson cancer centerOutpace cancerOutpace cancer raceSciences center

Norman Regional expanding again with a new cancer center

Bremner Real Estate specializes in development, management and strategic healthcare business planning. It's expanding Norman Regional Health again.

United statesNew yorkAlmonte shopping centerJay cohlmiaPerri dunnKris davisDanny ojedaMichael almarazDanny riveraKevin knueChris robertsBrandon birdwellInvicto futsalAaron diehlCraig tuckerLevi ballard

Elahere Gets Full Approval for Platinum-Resistant Ovarian Cancer

Conversion to regular approval from accelerated approval was based on data from the confirmatory phase 3 MIRASOL trial.

Kathleen mooreStephenson cancer centerUniversity of oklahomaDrug administration

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.